Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.90
+0.09 (0.92%)
At close: Apr 28, 2026, 4:00 PM EDT
9.88
-0.02 (-0.20%)
Pre-market: Apr 29, 2026, 7:15 AM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $585.24 million as of April 29, 2026. Its market cap has increased by 64.86% in one year.
Market Cap
585.24M
Enterprise Value
457.43M
1-Year Change
64.86%
Ranking
Category
Stock Price
$9.90
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $585.24M, an increase of 324.70%. That is a compound annual growth rate of 14.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 576.00M | 14.20% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forte Biosciences | 642.55M |
| Prothena Corporation | 602.93M |
| CorMedix | 602.33M |
| Aclaris Therapeutics | 593.51M |
| Ocugen | 592.40M |
| Shattuck Labs | 589.54M |
| Rigel Pharmaceuticals | 570.85M |
| ProKidney | 570.71M |